Serum IL-13 Predicts Response to Golimumab in Bio-Naïve Ulcerative Colitis

A certain number of patients with ulcerative colitis (UC) are refractory to anti-TNF-α antibodies; biomarkers are thus needed to predict treatment efficacy. This study aimed to evaluate whether serum biomarkers that were reported to be associated with UC or anti-TNF-α antibody could predict the resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Kinoshita, Naohiko, Kakimoto, Kazuki, Shimizu, Hikaru, Nishida, Koji, Numa, Keijiro, Kawasaki, Yuka, Tawa, Hideki, Nakazawa, Kei, Koshiba, Ryoji, Hirata, Yuki, Sakiyama, Naokuni, Koubayashi, Eiko, Takeuchi, Toshihisa, Miyazaki, Takako, Higuchi, Kazuhide, Nakamura, Shiro, Nishikawa, Hiroki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456517/
https://www.ncbi.nlm.nih.gov/pubmed/36078882
http://dx.doi.org/10.3390/jcm11174952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456517/
https://www.ncbi.nlm.nih.gov/pubmed/36078882
http://dx.doi.org/10.3390/jcm11174952

Ejemplares similares